IndiaTickerLatest filing: Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
ObservedCompany dossier
Torrent Pharmaceuticals
NSE:TORNTPHARM · ISIN INE685A01028
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Torrent Pharmaceuticals
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Mar 2026 · revenue ₹4,197 Cr · PAT ₹364 Cr.
Exchange XBRLLatest ownership: promoter group 60.78% and public 39.22% as of 20 Jul 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE · conference call
Observed
Source filing Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recording
BSE · conference call recording
Observed
Source filing Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Cessation
BSE · exchange filing
Observed
Source filing Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Change in Management
BSE · exchange filing
Reported financials
Full financials →31 Mar 2026
- Revenue from operations
- ₹4,197 Cr
- Profit after tax
- ₹364 Cr
- EPS
- ₹11.51
Observed BSE structured filing · consolidated
Ownership
Full shareholding →20 Jul 2026
- Promoter group
- 60.78%
- Public
- 39.22%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL